Updates matching "Access to Health Care"

Columbus, OH – Sept. 19, 2017 — Today, the American Cancer Society Cancer Action Network (ACS CAN) sent a letter to Governor Kasich calling on him to oppose a new proposal to repeal and replace the current health care law offered by Senators Graham and Cassidy. Instead, the letter calls

This week the Senate HELP Committee is hearing from bipartisan health care experts in its ongoing effort to strengthen the individual insurance market and ensure that meaningful, affordable health care coverage is available for millions of Americans, including cancer patients, survivors and their families.

U.S. Senator Patty Murray (D-WA) received the National Distinguished Advocacy Award, the most esteemed award presented by the American Cancer Society Cancer Action Network (ACS CAN) for her dedication to protecting patient access to adequate and affordable health care coverage, increasing federal cancer research funding and her career-long support for policies and programs intended to end death and suffering from cancer.

Eunice Hosttetter, a breast cancer survivor from Kirkland, Wash., was honored as the State Lead Ambassador of the Year by the American Cancer Society Cancer Action Network (ACS CAN) for her commitment to cancer advocacy.

The Congressional Budget Office (CBO) today released its assessment of what would happen to health insurance premiums should the administration stop paying cost-sharing reductions (CSRs). The CBO projects the average monthly premiums would increase 20 percent next year and 25 percent by 2020.

PROVIDENCE – AUGUST 3 – Rhode Island is getting mixed reviews when it comes to supporting policies and passing legislation to prevent and reduce suffering and death from cancer. According to the latest edition of How Do You Measure Up?: A Progress Report on State Legislative Activity to Reduce Cancer

The Senate has advanced the U.S. Food and Drug Administration’s (FDA) Reauthorization Act, which expands four separate user fee agreements on new drugs, generic drugs, medical devices, and biosimilars, and includes a provision to maximize the development of therapies for children with cancer.